Alfuzosin
|
|
- CAS-Nr.
- 81403-80-7
- Englisch Name:
- Alfuzosin
- Synonyma:
- Afluzosin;ALFUZOSIN;ALFUZOCIN;Alfuzosion;ALFUZOSINE;Alfuzosin Impurity;Alfuzosin USP/EP/BP;Alfuzosin (SL 77499);ALFUZOSIN HYDROCLORIDE;N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-methylamino]propyl]-2-oxolanecarboxamide
- CBNumber:
- CB4332422
- Summenformel:
- C19H27N5O4
- Molgewicht:
- 389.45
- MOL-Datei:
- 81403-80-7.mol
|
Alfuzosin Eigenschaften
- Schmelzpunkt:
- 178-180 °C
- Dichte
- 1.272±0.06 g/cm3(Predicted)
- storage temp.
- -20°C Freezer
- L?slichkeit
- DMSO (Sparingly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 14.80±0.20(Predicted)
- Farbe
- White to Off-White
- CAS Datenbank
- 81403-80-7(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H373 |
Kann die Organe sch?digen bei l?ngerer oder wiederholter Exposition. |
Spezifische Zielorgan-Toxizit?t (wiederholte Exposition) |
Kategorie 2 |
Warnung |
|
P260, P314, P501 |
|
Sicherheit |
P260 |
Dampf/Aerosol/Nebel nicht einatmen. |
P314 |
Bei Unwohlsein ?rztlichen Rat einholen / ?rztliche Hilfe hinzuziehen. |
P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Alfuzosin Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Alfuzosin hydrochloride is a post-synaptic a-antagonist useful in the symptomatic
treatment of benign prostatic hypertrophy and acute adenoma by lowering urethral
contractions induced by alpha, stimulation. Alfuzosin is also being developed as an
antihypertensive; its efficacy in this indication is comparable to prazosin with no
significant change in heart rate.
Verwenden
dietary supplement
Allgemeine Beschreibung
Alfuzosin is also a quinazoline 1-blockerbut differs from terazosin in replacing the piperazine ring interazosin with an open piperazine ring (a rotatable propylenediaminegroup). Alfuzosin is more selective for thesubtype of α1A-receptor in the prostate gland than those invascular tissue. Thus, it has been used extensively in treatingBPH as a first-line drug with fewer cardiovascular sideeffects than terazosin and doxazosin.
Alfuzosin Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Alfuzosin Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 139)Lieferanten
81403-80-7()Verwandte Suche:
- n-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)methylamino]propyl]tetrahydrofuran-2-carboxamide
- ALFUZOCIN
- ALFUZOSIN
- ALFUZOSIN HYDROCLORIDE
- ALFUZOSINE
- 2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl) methylamino]propyl]tetrahydro-
- N-[3-[(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]oxolane-2-carboxamide
- N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide
- Afluzosin
- Alfuzosion
- (2R)-N-{3-[(4-aMino-6,7-diMethoxyquinazolin-2-yl)(Methyl)aMino]propyl}oxolane-2-carboxaMide
- N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-methylamino]propyl]-2-oxolanecarboxamide
- Alfuzosin (SL 77499)
- Alfuzosin USP/EP/BP
- AlfuzosinQ: What is
Alfuzosin Q: What is the CAS Number of
Alfuzosin Q: What is the storage condition of
Alfuzosin Q: What are the applications of
Alfuzosin
- Alfuzosin Impurity
- 81403-80-7
- C19H27N5O4
- C19H28ClN5O4
- NUTRESTORE
- Pharmaceutical intermediate
- APIs
- Adrenoceptor